Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Johnson & Johnson

Market Cap 580B 501B 461B 432B 810B 55,113B 822B 5,449B 2,125B 26,825B 2,176B 2,130B 92,883B P/E Ratio 2026 *
25.7x
P/E Ratio 2027 * 23.3x
Enterprise Value 598B 517B 476B 446B 835B 56,865B 848B 5,622B 2,192B 27,678B 2,245B 2,197B 95,836B EV / Sales 2026 *
5.93x
EV / Sales 2027 * 5.48x
Free-Float
77.1%
Yield 2026 *
2.22%
Yield 2027 * 2.31%
1 day+1.07%
1 week+3.48%
Current month+6.90%
1 month+4.54%
3 months-0.27%
6 months+13.84%
Current year+16.39%
1 week 230.41
Extreme 230.41
241.6
1 month 220.84
Extreme 220.84
241.6
Current year 200.91
Extreme 200.9101
251.71
1 year 149.04
Extreme 149.04
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 109.16
Extreme 109.16
251.71
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 60 05/11/2019
Director TitleAgeSince
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
Chairman 63 02/01/2023
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

215 0.0000%
09/06Free

Director

134 0.0000%
09/06Free

Director

161 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%+3.48%+53.32%+49.85% 580B
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
+0.15%+0.65%+6.81%-34.93% 149B
Average +0.22%+0.82%+17.72%+37.35% 357.83B
Weighted average by Cap. -0.21%+1.02%+26.89%+66.14%

Financials

2026 *2027 *
Net sales 101B 87.14B 80.3B 75.16B 141B 9,590B 143B 948B 370B 4,668B 379B 371B 16,162B 107B 92.65B 85.38B 79.92B 150B 10,196B 152B 1,008B 393B 4,963B 403B 394B 17,184B
Net income 22.05B 19.05B 17.55B 16.43B 30.79B 2,096B 31.27B 207B 80.8B 1,020B 82.76B 81B 3,533B 24.34B 21.03B 19.38B 18.14B 33.99B 2,314B 34.52B 229B 89.2B 1,126B 91.37B 89.42B 3,900B
Net Debt 18.44B 15.92B 14.67B 13.73B 25.74B 1,752B 26.14B 173B 67.55B 853B 69.19B 67.72B 2,953B 8.04B 6.94B 6.4B 5.99B 11.22B 764B 11.4B 75.55B 29.46B 372B 30.17B 29.53B 1,288B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
12/06/26 240.87 $ +1.07% 6,459,438
11/06/26 238.33 $ -0.07% 7,398,981
10/06/26 238.49 $ +0.63% 8,350,790
09/06/26 237.00 $ +2.08% 8,354,459
08/06/26 232.16 $ -0.26% 7,559,782
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
240.87USD
Average target price
252.87USD
Spread / Average Target
+4.98%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!